IGF-1 DES
Insulin-Like Growth Factor-1 Des(1-3)
A truncated form of IGF-1 that is significantly more potent for muscle growth due to reduced binding to IGF-binding proteins.
Typical Cost
$100-200/vial (1mg)
Status
Research
Peptide Profile
IGF-1 DES
Mechanism of Action
Lacks the N-terminal tripeptide which allows it to evade IGF-binding proteins, resulting in higher free concentrations and more potent anabolic effects on muscle tissue.
Common Dosages
subcutaneous or intramuscular
20-50mcg
1-2x daily · 4-6 weeks
Benefits
Extreme muscle growth
Site-specific growth
Rapid recovery
More potent than IGF-1 LR3
Side Effects
Hypoglycemia risk
Organ growth
Acromegaly features
Banned in sports
Cancer concerns
Key Research
IGF-1 DES potency
Demonstrated 10x higher potency than IGF-1 for muscle growth
Regulatory Status
Research chemical only. Not FDA-approved. Banned by all sports organizations.
Contraindications
- ⚠Diabetes
- ⚠Active cancer
- ⚠All populations - high risk
Not appropriate. SeraVia Muscle+ Protect offers safe, legal muscle support without these risks.
Learn More →Find peptide providers
Search 18,000+ clinics offering peptide therapy alongside GLP-1 medications.
Search Providers →Disclaimer: This information is for educational and research purposes only. Peptides described here may not be FDA-approved for human use. Always consult a qualified healthcare provider before using any peptide product. GLP1Search does not sell peptides.